Remove 2010 Remove Epilepsy Remove Safety Remove Treatment
article thumbnail

Article: Who is Impacted if Marijuana is Reclassified as a Schedule II Drug

Cannabis Law Report

She was the Presiding Judge 2009 and 2010 and the co-founder of the Denver County Court Sobriety Court. It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.” Author Biography.

article thumbnail

Lighting Up Florida’s Medical Marijuana PEOPLE: The Front Lines

Cannabis Law Report

I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis. First and foremost, I’ll highlight the patient perspective, patients like myself who are legally registered State of Florida Medical Marijuana active ID cardholders. Sally Kent Peebles.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

article thumbnail

Panaxia’s facility in Malta granted EU-GMP Standard

Cannabis Law Report

In addition, Panaxia is the only company in Europe to have a regulatory permit for the distribution of medical cannabis tablets in France , as part of the French National Agency for Medicines and Health Products Safety (ANSM). About Panaxia Labs Israel. Panaxia Labs Israel, Ltd., Assi Rotbart (LL. The Panaxia Group has over 150 employees.

article thumbnail

A New Treatment: CBD Oil For Autism?

Puff Puff Post

With so many people affected by autism and incidence rates having increased by 119% between the years 2000 to 2010, it has gained the status of the quickest-growing developmental disability. The Current Treatments for Autism. million USD for their study regarding the safety and efficacy of CBD therapy for autism in children.

article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. Many of these are meant to address public safety risks, especially for young people. Both THC and CBD are psychoactive, but unlike THC, CBD does not intoxicate.

Law 40